Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research TeamReviewed Apr 8, 20268 Citations

Bivalirudin (Angiomax) peptide icon, one bubble per amino acidBivalirudin (Angiomax)20 residuesFPRPGGGGNGDFEEIPEEYLEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Bivalirudin (Angiomax) Dosage Calculator

Immune · FDA Approved · Grade B · 25 min half-life · Injection

Dosing protocol

Bivalirudin (Angiomax) Dosage

LevelDose / InjectionFrequency
Beginner750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure
Moderate750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure
Aggressive750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure

No syringe calculation for this route

Intravenous

Bivalirudin (Angiomax) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 750 mcg/kg to 750 mcg/kg per administration, iv bolus, then 1.75 mg/kg/h infusion for the procedure.

This peptide is prepared by a hospital or research pharmacy and given under medical supervision. There is no home mix to calculate.

Open Bivalirudin (Angiomax) details
Side effects, protocols by goal, storage, and the sources behind these dosing numbers.

About Bivalirudin (Angiomax)

Beginner, moderate, and aggressive dosing amounts with timing. Free to use.

Bivalirudin (Angiomax) is an FDA-approved direct thrombin inhibitor used during coronary stent procedures. The HORIZONS-AMI trial showed 41% lower major bleeding versus heparin-based regimens. Its 25-minute half-life allows rapid offset, and it eliminates the risk of heparin-induced thrombocytopenia entirely. Hospital-only IV administration.

FDA-ApprovedDirect Thrombin InhibitorPCI AnticoagulantHIT AlternativeAcute Cardiac Care
Intravenous. Typical beginner frequency: iv bolus, then 1.75 mg/kg/h infusion for the procedure.
Store at 20-25°C (lyophilized); 2-8°C (reconstituted). Store at 20-25°C (68-77°F); excursions permitted to 15-30°C. Protect from light.

View side effects and safety warnings →

Quick-Start: How to Use Bivalirudin (Angiomax)

  1. 1Confirm patient weight in kilograms. All dosing is weight-based. A miscalculated weight is the leading cause of subtherapeutic ACT.
  2. 2Reconstitute one 250 mg vial with 5 mL Sterile Water for Injection. Gently swirl until dissolved (50 mg/mL concentrate).
  3. 3Withdraw the required volume and dilute in 50 mL of D5W or 0.9% sodium chloride to achieve a 5 mg/mL working solution.
Full usage guide →

Bivalirudin (Angiomax) Dosing Protocol

FDA LabelANGIOMAX (bivalirudin) FDA Prescribing Information (2019)
LevelDose / InjectionFrequency
Beginner750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure
Moderate750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure
Aggressive750 mcg/kgIV bolus, then 1.75 mg/kg/h infusion for the procedure
Note:

This is a hospital-only IV drug. You won't be reconstituting this at home; cath lab pharmacists and nurses handle preparation under physician supervision.

Reconstitution math for the record: each 250 mg vial gets 5 mL of Sterile Water for Injection (SWFI), giving a 50 mg/mL concentrate. That concentrate then gets diluted into 50 mL of D5W or 0.9% NaCl for a final working concentration of 5 mg/mL.

For an 80 kg patient, the bolus is 60 mg (0.75 mg/kg x 80 kg), which works out to 12 mL from the 5 mg/mL solution. The procedural infusion runs at 140 mg/h (1.75 mg/kg/h x 80 kg), so 28 mL/h from the same bag.

The non-obvious thing most clinicians miss early on: a subtherapeutic ACT at the 5-minute check almost always traces back to a weight calculation error. Recheck actual body weight before giving the supplemental 0.3 mg/kg bolus. Estimated weights in emergency STEMI settings cause real dosing errors.

Dosing based on ANGIOMAX (bivalirudin) FDA Prescribing Information (2019): 8 published references.View all sources →

Ask AI about this math

Cross-check your Bivalirudin (Angiomax) reconstitution math with AI

Bivalirudin (Angiomax) Cost

Brand Price
Angiomax (Pfizer/The Medicines Company): largely displaced by generics; branded product not typically on current hospital formularies
Generic / Research
Multiple generics available: Sandoz (authorized generic, first to market), Hospira/Pfizer, Mylan/Viatris, Meitheal. Hospital acquisition cost: ~$143–418 per 250 mg vial / ~$143–214 per PCI case (generic era). Retail (Drugs.com): ~$311–420 per vial. Compare: UFH per PCI case ~$4–10.
Compounded
Not applicable: pharmaceutical-grade IV product; compounding not part of clinical use pathway

Pricing updated 2026-04-09

Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →

Bivalirudin (Angiomax) Pharmacokinetics

Pharmacokinetics: Active Dose Over Time

t½ = 25 minutes (normal renal function); 34-57 minutes (moderate-severe renal impairment); 3.5 hours (dialysis patients)
50%25%12.5%100%75%50%25%0%046m91m2h3h4hTime after injectionDose remaining
After 1 half-life (46m): 50% remainsAfter 2 half-lives (91m): 25% remainsAfter 3 half-lives (2h): 12.5% remains
At a 750 mcg/kg dose: 50% = 375 mcg/kg remaining after 46m. Moderate-tier frequency in our sources: IV bolus, then 1.75 mg/kg/h infusion for the procedure.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Read the full Bivalirudin (Angiomax) guide →

Related Tools

Frequently Asked Questions

Store Bivalirudin (Angiomax) at 20-25°C (lyophilized); 2-8°C (reconstituted). Store at 20-25°C (68-77°F); excursions permitted to 15-30°C. Protect from light.